Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tek_jansen500 tek_jansen500 Sep 3, 2011 4:51 PM Flag

    Faster generics approvals; good for MNTA

    Good point. Still, do we really think the additional resources for generics approvals will *only* go to new ANDA's?

    Let's say genericX files today, and tomorrow the legislation is approved. Day after tomorrow genericY files and pays the extra fee. Is genericX really going to still have a 31 month timeline, while genericY gets approved in 10 months?

    Maybe. But I would guess (hope) that some of the new resources would also go to clearing the existing backlog (M-Copaxone included) along with speeding new approvals.

 
MNTA
11.77-0.65(-5.23%)Feb 5 3:59 PMEST